for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Moleculin Reports Submission To Expand Clinical Sites In European AML Trial

June 4 (Reuters) - Moleculin Biotech Inc:

* MOLECULIN ANNOUNCES SUBMISSION TO EXPAND CLINICAL SITES IN EUROPEAN AML TRIAL

* MOLECULIN BIOTECH - SUBMITS REGULATORY REQUESTS TO OPEN TWO ADDITIONAL CLINICAL SITES IN POLAND

* MOLECULIN BIOTECH - ASSUMING REQUESTS ARE GRANTED, EXPECT ADDITIONAL SITES TO BEGIN RECRUITING IN Q3 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up